Biolase, Inc. (BIOLQ) vs Beyond Air, Inc. (XAIR)
- Biolase, Inc. BIOLQ 0.00 NaN
- Beyond Air, Inc. XAIR 2.16 −2.26%
Biolase, Inc. and Beyond Air, Inc. are both Medical Devices companies. Biolase, Inc. and Beyond Air, Inc. are of similar size ($2.3M and $2.2M). Beyond Air, Inc. grew revenue faster over the last twelve months: 60.8% against −7.44%. Biolase, Inc. has the higher net margin (−71.8% vs −435.7%) and the higher return on invested capital (−109.5% vs −174.9%). Across the 16 metrics below, Biolase, Inc. leads on 14 and Beyond Air, Inc. on 2.
Valuation
Profitability
| Metric | BIOLQ | XAIR | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | 4.18% | 56.01% |
| Operating margin | (29.37%) | (364.76%) | (15.03%) |
| Net margin | (71.75%) | (435.71%) | (20.40%) |
| Free cash flow margin | (28.55%) | (254.96%) | (7.24%) |
| Return on equity | 1,349.30% | (505.67%) | (15.32%) |
| Return on assets | (100.09%) | (109.80%) | (19.72%) |
| Return on invested capital | (109.48%) | (174.89%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack